Mechanism
Synthetic peptide with signals for connective-tissue and GI healing in animal models.
TechnicalGHRGFLVEGYHTLNDKIAHGV — reported to upregulate growth factor receptors (e.g., VEGFR2) and modulate NO pathways. Mechanism not fully characterized.GHRGFLVEGYHTLNDKIAHGV
Reported uses by species
| Species | Indication | Tier | Honest evidence note |
|---|---|---|---|
| Dogs | Ligament (ACL) healing, post-surgical recovery, GI protection | Investigational | Used by some integrative veterinarians. |
| Horses | Soft-tissue recovery | Investigational | Anecdotal clinical use; not RCT-supported in species. |
Suggested starting protocol
Starting points only — clinical judgment required. Dosing unlocks for verified veterinary accounts.
Professional-use acknowledgment
Confirm you are a veterinary professional
Dosing tables on monographs are for licensed veterinary professionals using independent clinical judgment.
- • I am a licensed veterinary professional accessing this content for clinical use.
- • I will exercise independent clinical judgment for every patient.
- • I understand evidence labels reflect the current state of published research.
Monitoring, contraindications & do-not-use-if
Virtually all published evidence is from rodent models. Not FDA-approved. Use under veterinary discretion only; informed-consent discussion with client is essential.
The evidence
- Peptides for Veterinary Applications — PeptideJournalPeptideJournal
- CIVT veterinary webinar — investigational peptides in practiceCIVT